Recent Faculty Publications

We share our research studies with physicians and scientists worldwide through publications in leading academic journals. View a listing of our faculty’s most recent publications.

Remi Adelaiye-Ogala, PhD

  • Surendra Gulla, Tej Sharma, Ephraim Gardner, Chennan Li, Tanaya A. Purohit, Chao Xue, Sean Colligan, Shreya Shyam Sundar, Bing Yang, Shana Y. Trostel, Brian Capaldo, Jonathan E Bard, Tobi Ogunbowale, Abbas Jawadwala, Min Ma, Jun Qu, Fatima Karzai, Roberto Pili, David F. Jarrard, Adam G. Sowalsky, David J. VanderWeele, Remi Adelaiye-Ogala. (2026) MECOM Function is Critical for AR-Driven Treatment-Resistant Prostate Cancer. AACR Cancer Research (Jan) doi:10.1158/0008-5472
  • Sarah E Kohrt, Emily J Novak, Subhashish Tapadar, Bocheng Wu, Jonathan Strope, Yaw Asante, Hyunmin Kim, Matthew S Chang, Douglas Gurdak, Athar Khalil, Michael Rood, Eric Raftery, Diana Stavreva, Holly M Nguyen, Lisha G Brown, Maddy Ramser, Cody Peer, Warren M Meyers, Nicholas Aboreden, Maharshi Chakravortee, Richard Sallari, Peter S Nelson, Kathleen K Kelly, Thomas G W Graham, Xavier Darzacq, William D Figg, Adegboyega K Oyelere, Eva Corey, Remi Adelaiye-Ogala, Berkley E Gryder. (2024) Small-molecule disruption of androgen receptor-dependent chromatin clusters. Proc Natl Acad Sci U S A (Nov), 121 doi:10.1073/pnas.2406239121
  • Lynda Bennett, Praveen Kumar Jaiswal, Ryan V Harkless, Tiha M Long, Ning Gao, Brianna Vandenburg, Phillip Selman, Ishrat Durdana, Ricardo R Lastra, Donald Vander Griend, Remi Adelaiye-Ogala, Russell Z Szmulewitz, Suzanne D Conzen. (2023) Glucocorticoid receptor (GR) activation is associated with increased cAMP/PKA signaling in castrate-resistant prostate cancer. Molecular Cancer Therapeutics, AACR Journal (Nov) doi:10.1158/1535-7163.MCT-22-0479

Nikolaos Almyroudis, MD

Roberto Pili, MD